Azor 10 MG / 20 MG Oral Tablet
- RxCUI
- 744624
- RxNorm name
- Azor 10 MG / 20 MG Oral Tablet
- Display name
- Azor 10 MG / 20 MG Oral Tablet
- Full name
- Azor 10 MG / 20 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azor | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | Cosette Pharmaceuticals, Inc. | c5535406-b63b-49aa-88b9-169aaf0ed08e | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 744624 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c5535406-b63b-49aa-88b9-169aaf0ed08e | Azor 10 MG / 20 MG Oral Tablet [PSN] · amlodipine 10 MG / olmesartan medoxomil 20 MG Oral Tablet [Azor] [SBD] · Azor (amlodipine 10 MG (amlodipine besylate 13.9 MG) / olmesartan medoxomil 20 MG) Oral Tablet [SY] · Azor 10/20 Oral Tablet [SY] | 4 | 4 | These highlights do not include all the information needed to use AZOR safely and effectively. See full prescribing information for AZOR . AZOR (amlodipine and olmesartan medoxomil) tablets , for oral use Initial U.S. Approval: 200 7 | 20230712 |